whytestocks Tuesday, 01/22/19 07:41:50 AM Re: None Post # of 1491 News: $CYTK Cytokinetics Announces Receipt of FDA Feedback Regarding Reldesemtiv in Patients With SMA SOUTH SAN FRANCISCO, Calif., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it has received feedback from the U.S. Food and Drug Administration (FDA) that the Six Minute Walk Test (6MWT) is an acceptable primary efficacy endpoint for a poten... Read the whole news https://marketwirenews.com/news-releases/cytokinetics-announces-receipt-of-fda-feedback-regarding-reldesemtiv-in-patients-with-sma-7414652.html